Photocure ASA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Photocure ASA with three other
companies in this sector in Norway:
Biotec Pharmacon ASA
sales of 66.69 million Norwegian Kroner [US$7.77 million]
(66.42 million Norwegian Kroner [US$7.74 million]
of which 100%
was Vitamin K2/MenaQ7), and
Vistin Pharma ASA
(176.69 million Norwegian Kroner [US$20.60 million]
During the year ended December of 2017, sales at
Photocure ASA were NOK 150.91 million (US$17.59 million).
increase of 5.1%
versus 2016, when the company's sales were NOK 143.63 million.
This was the fourth straight year of sales growth at Photocure ASA.
Sales of Hexvix/cysview Own Sales saw an increase
that was more than double the company's growth rate: sales were up
23.3% in 2017, from
NOK 69.50 million to NOK 85.72 million.
Not all segments of Photocure ASA experienced an increase in sales in 2017:
sales of Other Sales fell 96.8% to NOK 166,000.00 .
(However, this segment's sales were only a very small portion of the company's overall sales).